AlphaCentric Advisors »

Jones Lang LaSalle Incorporated shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Jones Lang LaSalle Incorporated (JLL) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Jones Lang LaSalle Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Jones Lang LaSalle Incorporated held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jones Lang LaSalle Incorporated by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $87k 286 304.32

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Astrazeneca Ord (AZN)
Vertex Pharmaceuticals Incorporated (VRTX)
Euronet Worldwide (EEFT)
Invitation Homes (INVH)
Ionis Pharmaceuticals (IONS)
Insmed Com Par $.01 (INSM)
Incyte Corporation (INCY)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
AMREP Corporation (AXR)
Saul Centers (BFS)

View all positions for AlphaCentric Advisors

Top funds holding Jones Lang LaSalle Incorporated

Vanguard Group
BlackRock
Vanguard Portfolio Management
FMR
Vanguard Capital Management
Edgepoint Investment
Morgan Stanley
State Street Corporation
Ariel Investments
Geode Capital Management
Dimensional Fund Advisors
AQR Capital Management
Massachusetts Financial Services
Millennium Management
Alliancebernstein

View all funds holding Jones Lang LaSalle Incorporated